Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 2:07 p.m.

    📋 Royalty Pharma plc (RPRX) - Business Combination

    Filing Date: 2022-05-11

    Accepted: 2022-05-11 11:32:01

    Event Type: Business Combination

    Event Details:

    Royalty Pharma (RPRX) Announces Business Combination Royalty Pharma (RPRX) has entered into a strategic transaction. Transaction Details:
    • Transaction: Pfizer to acquire Biohaven
    • Deal Value: $835 million
    • Timing: Expected to close early 2023

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Royalty Pharma
    • CIK: 0001802768
    • Ticker Symbol: RPRX
    • Period End Date: 2022-05-10
    • Document Type: 8-K

Search

News categories